Improved radiopharmaceuticals for imaging cerebral acetylcholinesterase (AChE) are needed for the diagnosis of Alzheimer's disease (AD). Thus, 11 C-labeled (−)-galanthamine and its enantiomers were synthesized as novel agents for imaging the localization and activity of AChE by positron emission tomography (PET). C-11 was 
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Sagittal PET image of (−)-[ 11 C]galanthamine in the ddY mouse.
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Introduction
The function of the brain cholinergic system, where acetylcholine (ACh), acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) act to control the potential of nerve cells, is crucial to memory, learning, and recognition. Decreases in the activities of AChE and ChAT have been observed in the brains of patients suffering from Alzheimer's disease (AD), while increased activity of AChE in some regions, for example the hippocampus and striatum, has been correlated with cognitive decline in AD patients. 1 Thus, some AChE inhibitors have been approved for treating mild to moderate AD.
Because noninvasive methods for visualizing AChE levels would be useful for monitoring the treatment and progression of AD, studies have been performed using the substrate-type PET tracer, [ 11 C]MP4A.
2−4 Other derivatives of AChE inhibitors, such as
Galanthus woronowii and Lycoris radiata, was also developed as a treatment for AD because it showed several biological activities, including allosteric modulation of the nicotinic acetylcholine receptor, and inhibition of AChE. 8 Meanwhile, we have reported a novel synthetic route to (±)-galanthamine and (−)-galanthamine which avoids the use of narwedine (which causes a fatal allergic response in some workers. 9, 10 ) as an intermediate.
Thus, we examined the potential of (−)-and (+)-[ 11 C]galanthamine (Figure 1)
as PET probes in in vitro and in vivo experiments.
Materials and methods

General
1 H and 13 C NMR spectra were recorded on a JNM-AL400 spectrometer (JEOL, Tokyo, Japan) with CDCl 3 as a solvent and tetramethylsilane (0.00) as an internal standard.
Mass spectra (MS) were obtained using a JMS-HX/HX110 A spectrometer (JEOL, Tokyo, Japan). Specific rotations were measured on a p-1020 digital polarimeter (Jasco, = 10.6 Hz, 0.5H). at −78°C, and the resulting mixture was stirred at this temperature for 2 h. Acetone (3 mL) was then added to quench the reaction, and organic solvents in the mixture were then removed in vacuo. Methanol (25 mL) was added to the residue to give a precipitate, which was collected by filtration. Recrystallization of this precipitate from methanol gave (±)-norgalanthamine as colorless crystals (780 mg, 84% 288.1600).
(−)-and (+)-Galanthamine
A solution of (+)-and (−)-norgalanthamine (0.46 mg), cesium carbonate (12.06 mg), and methyl triflate (4 L) in DMSO (50 L) was added to a sealable tube, which was then sealed, and the reaction mixture was stirred for 5 min at 170°C. The reaction mixture was analyzed using an HPLC system equipped with a Chiralcel IC column (4.6 × 250 mm, Daicel, Tokyo, Japan), and was separated using a mix of solvents (methyl 
Optical resolution
The optical resolution of (±)-norgalanthamine was performed on an HPLC system equipped with a Chiralcel IC column ( min, while that of (−)-and (+)-norgalanthamine was 7.5 min. The radiochemical purity of the labeled compounds was determined by analytical HPLC using the conditions described above.
Measurement of AChE Activity
The inhibitory activities of (−)-and (+)-galanthamine against AChE were measured using a modified version of the colorimetric method of Ellman. 
Biodistribution studies
Either ( The images were analyzed using a bio-imaging analyzer (BAS5000, Fujifilm Photo Film, Tokyo, Japan) and Image Gauge software (Fujifilm Photo Film).
In vitro autoradiographic experiments
PET studies
PET studies were performed using a GE Healthcare eXplore VISTA PET camera (GE Healthcare, Little Chalfont, UK). A seven-week-old male ddY mouse (20-25 g) was anesthetized (1.5% isoflurane) and (−)-[ 11 C]galanthamine (74 MBq, in 0.2 mL isotonic saline) was injected via the tail vein. Emission data from the animal were then collected for 10-30 min. The images were reconstructed using a 2-D ordered-set expectation-maximization algorithm.
Statistical analysis
Data are expressed as means ± SD. The statistical significance of differences was evaluated using the Tukey-Kramer test. A value of p < 0.05 was considered significant.
Results
Synthesis of galanthamine
The synthetic routes to (±)-galanthamine (1) N-methylation of 5 was attempted using methyl iodide or methyl triflate as the methylating agent. However, the former conditions gave no product, while the latter conditions provided only a low yield of (±)-galanthamine (33%). The overall yield of (±)-galanthamine from 2 was 25%.
(±)-Norgalanthamine (6) could be separated into optically pure (+)-and (−)-6 using an HPLC system equipped with a chiral column. 
Radiolabeling of (−)-and (+)
-
Measurement of AChE Activity
The AChE-inhibitory activities of ()-and (+)-galanthamine are shown in Table   1 . Percentage inhibition was measured by the Ellman method. Naturally occurring and synthesized ()-galanthamine showed similar potent inhibition of AChE (95 ± 1.0% and 94 ± 2.7%, respectively), while (+)-galanthamine exhibited only weak inhibition (10 ± 4.4%).
Biodistribution studies
The distributions of (−)-and (+)-[ ID/g for both compounds), at which point the brain:blood ratios of the compound were ~1.5:1.0.
The regional distribution of radioactivity in the mouse brain is shown in Figure   3 . Accumulation of (−)-[ 11 C]galanthamine was greater in the striatum (2.1% ID/g, AChE-rich region) than in the cerebellum (1.7% ID/g, an AChE-poor region). In contrast, there was no difference in accumulation of (+)-[ 11 C]galanthamine in these region (i.e., 1.5% ID/g for the striatum; 1.5% ID/g for the cerebellum).
Pretreatment with donepezil had no effect on striatal accumulation of (+)-[ 11 C]galanthamine, but did lead to a significant decrease in accumulation of (−)-[ 11 C]galanthamine (i.e. dose-dependently, to the basal level (1.3% ID/g, 4.6 mg/kg)).
In vitro autoradiographic experiments
In vitro autoradiographic analyses were performed (Figure 4 ) to investigate the regional distribution of (−)-[ 11 C]galanthamine in the brain in more detail. The radioactivity level was the highest in the striatum (Fig. 4b) , consistent with the distribution of AChE observed in immunostaining (Fig. 4a) . Furthermore, the effects of was synthesized efficiently in good overall yield (Scheme 1), and it was important to conduct the N-Methylation of (±)-norgalanthamine to (±)-galanthamine within a short time-period. An alternative route to 6 via reductive methylation of 5 was not explored, due to the difficulty in preparing and handling the required [ In vitro experiments indicated that (−)-galanthamine had inhibitory activity against AChE comparable with the activity of commercially available (−)-galanthamine hydrobromide, while (+)-galanthamine was only weakly active.
In the study of the biodistribution of (−)-and (+)-[ 11 C]galanthamine in normal mice, the total uptake amount of each isomer in brain was almost the same, which meant that the chirality of galanthamine had no effect on its ability to penetrate the blood-brain barrier.
In regional distribution studies in normal mouse brains, accumulation of (−)-[ 11 C]galanthamine was greater in the striatum than in the cerebellum. It is considered that these differences reflect the distribution of AChE in brain tissue. 7, 15 Meanwhile, the difference in the accumulation of (+)- 
Conclusion
We 
